Return to study ST002104 main page
MB Sample ID: SA201534
Local Sample ID: | Blank_1 |
Subject ID: | SU002189 |
Subject Type: | Cultured cells |
Subject Species: | Homo sapiens |
Genotype Strain: | OVCAR-5 and CaOV3 cell lines |
Gender: | Not applicable |
Cell Biosource Or Supplier: | CaOV3 was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). OVCAR-5 cell line obtained from Dr. Thomas Hamilton (Fox Chase Cancer Centre, Philadelphia, PA). |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR002201 |
Treatment Summary: | OVCAR-5 and CaOV3 cells were made resistant to carboplatinumv (CBP) after treatment with 6-8 cycles of CBP (50μM, Hospira Australia, Pty Ltd). Resistance to CBP was measured regularly and CBPR cell lines were seen to be at least two-fold more resistant to CBP than their parental partners through the following experiments. |
Treatment Compound: | 50μM carboplatinum, Hospira Australia, Pty Ltd |
Treatment Route: | in culture media |
Treatment Dose: | 6-8 cycles of CBP 50μM |